USA – Medical technology company BD (Becton, Dickinson and Company) has named Dr. Ronald Silverman as its new Executive Vice President and Chief Medical Officer, effective December 4, 2023.
Dr. Silverman assumes the role, succeeding Dr. William Sigmund, who revealed plans to retire earlier this year.
In his new position, Dr. Silverman will lead BD’s Medical Affairs organization, overseeing end-to-end medical affairs across the company’s business units, regions, and central team.
His responsibilities include leveraging medical insights to propel BD’s pipeline of innovative, clinically relevant solutions that align with the evolving needs of patients.
Additionally, Dr. Silverman will contribute to ensuring the safety and compliance of BD’s existing product portfolio.
Dr. Silverman will report to Beth McCombs, BD’s Executive Vice President, and Chief Technology Officer, and join the BD Executive Leadership Team.
Dr. Silverman brings a wealth of experience to BD, having served as Senior Vice President and Chief Medical Officer at 3M Health Care since 2021.
Dr. Silverman joins BD from 3M Health Care, where he most recently served as Senior Vice President and Chief Medical Officer since 2021.
His extensive experience includes leading Medical and Clinical Affairs teams for various business units within 3M, including KCI Corporation, Acelity Corporation, and 3M Health Care Medical Solutions Division.
Before his corporate roles, Dr. Silverman held the position of Chief of Plastic Surgery at the University of Maryland Medical Center.
He maintains academic appointments at both the University of Maryland and Johns Hopkins schools of medicine.
Notably, Dr. Silverman’s transition follows 3M’s strategic decision to spin off its healthcare business as an independent entity named Solventum in the first half of 2024.
Dr. Silverman, certified by The American Board of Plastic Surgery, earned his Bachelor of Arts and Doctor of Medicine degrees from the University of Maryland.
His surgical and plastic surgery training took place at Harvard’s Massachusetts General Hospital. Actively engaged in academia, he holds advisory board roles and memberships in professional organizations.
Dr. Silverman is recognized for his contributions, including two patents, over 80 journal publications, and contributions to several textbooks.